基底节血管周围间隙与新诊断帕金森病长期运动预后
本研究回顾248例未用药早期帕金森病患者的病历,基线MRI计数基底节扩大血管周围间隙(BG-PVS),分低数量组(0-10个,n=156)和高数量组(>10个,n=92),用Cox回归比较左旋多巴诱导运动障碍(LID)、剂末现象和冻结步态(FOG)的无事件时间。高数量组FOG风险更高,LID和剂末现象风险相当,且需更高剂量多巴胺能药物控制症状。
要点
- 基线基底节扩大血管周围间隙高数量与帕金森病冻结步态风险增加相关。
- 高数量组与低数量组左旋多巴诱导运动障碍和剂末现象风险相当。
- 高数量组需要更高剂量多巴胺能药物才能有效控制症状。
核心结论
- 基线基底节扩大血管周围间隙可作为帕金森病运动残疾进展的指标。
研究设计与样本
- 回顾248例未用药早期帕金森病患者病历,随访>3年,平均年龄67.44±8.46岁,女性130例,基线均行脑MRI和多巴胺转运体(DAT)扫描。
- 按基线扩大BG-PVS数量分低数量组(0-10个,n=156)和高数量组(>10个,n=92)。
- 用Cox回归比较LID、剂末现象和FOG的无事件时间,用线性混合模型比较左旋多巴等效剂量/体重的纵向增加。
主要发现
- 高数量组年龄更大(72.28±6.07岁 vs 64.58±8.38岁),小血管病负担更重。
- 高数量组除腹侧纹状体外,所有纹状体亚区DAT可用性下降更严重。
- 高数量组FOG风险更高,但LID和剂末现象风险两组相当。
- 高数量组需要更高剂量多巴胺能药物才能有效控制症状。
临床怎么用
- 对早期帕金森病患者可评估基线基底节扩大血管周围间隙数量,辅助识别冻结步态和运动残疾进展风险较高者。
- 高数量患者可能需要更密切监测运动并发症并调整多巴胺能药物剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association between enlarged perivascular spaces (PVS) in the basal ganglia (BG-PVS) and long-term motor outcomes in Parkinson disease (PD). METHODS: We reviewed the medical records of 248 patients with drug-naive early-stage PD (follow-up >3 years, mean age 67.44 ± 8.46 years, 130 female) who underwent brain MRI and dopamine transporter (DAT) scans at initial assessment. The number of baseline enlarged BG-PVS was counted on axial T2-weighted images. Then, patients were divided into 2 groups: a PD group with a low number (0-10) of enlarged PVS (PD-EPVS-; n = 156) and a PD group with a high number (>10) of enlarged PVS (PD-EPVS+; n = 92). We used Cox regression models to compare the levodopa-induced dyskinesia (LID)-, wearing-off-, and freezing of gait (FOG)-free times between groups. We also compared longitudinal increases in levodopa-equivalent dose per body weight between groups using a linear mixed model. RESULTS: Patients in the PD-EPVS+ group were older (72.28 ± 6.07 years) and had greater small vessel disease burden than those in the PD-EPVS- group (64.58 ± 8.38 years). The PD-EPVS+ group exhibited more severely decreased DAT availability in all striatal subregions except the ventral striatum. The risk of FOG was higher in the PD-EPVS+ group, but the risk of LID or wearing-off was comparable between groups. The PD-EPVS+ group required higher doses of dopaminergic medications for effective symptom control compared to the PD-EPVS- group. CONCLUSION: This study suggests that baseline enlarged BG-PVS can be an indicator of the progression of motor disability in PD.
引用
- Chung SJ, Yoo HS, Shin NY, et al. Perivascular Spaces in the Basal Ganglia and Long-term Motor Prognosis in Newly Diagnosed Parkinson Disease. Neurology. 2021. PMID: 33653906. doi:10.1212/WNL.0000000000011797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。